IL145630A0 - Method for a programmed controlled ovarian stimulation protocol - Google Patents

Method for a programmed controlled ovarian stimulation protocol

Info

Publication number
IL145630A0
IL145630A0 IL14563000A IL14563000A IL145630A0 IL 145630 A0 IL145630 A0 IL 145630A0 IL 14563000 A IL14563000 A IL 14563000A IL 14563000 A IL14563000 A IL 14563000A IL 145630 A0 IL145630 A0 IL 145630A0
Authority
IL
Israel
Prior art keywords
stimulation protocol
ovarian stimulation
controlled ovarian
programmed controlled
programmed
Prior art date
Application number
IL14563000A
Other languages
English (en)
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of IL145630A0 publication Critical patent/IL145630A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14563000A 1999-03-31 2000-03-21 Method for a programmed controlled ovarian stimulation protocol IL145630A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12724199P 1999-03-31 1999-03-31
US13163299P 1999-04-28 1999-04-28
PCT/EP2000/002466 WO2000059542A1 (en) 1999-03-31 2000-03-21 Method for a programmed controlled ovarian stimulation protocol

Publications (1)

Publication Number Publication Date
IL145630A0 true IL145630A0 (en) 2002-06-30

Family

ID=26825471

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14563000A IL145630A0 (en) 1999-03-31 2000-03-21 Method for a programmed controlled ovarian stimulation protocol
IL145630A IL145630A (en) 1999-03-31 2001-09-25 Method for a programmed controlled ovarian stimulation protocol

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL145630A IL145630A (en) 1999-03-31 2001-09-25 Method for a programmed controlled ovarian stimulation protocol

Country Status (28)

Country Link
US (1) US8173592B1 (cs)
EP (1) EP1165138B1 (cs)
JP (1) JP4616999B2 (cs)
KR (1) KR100679880B1 (cs)
CN (1) CN1346281B (cs)
AR (1) AR023249A1 (cs)
AT (1) ATE265862T1 (cs)
AU (1) AU768544B2 (cs)
BG (1) BG65270B1 (cs)
BR (1) BR0009477A (cs)
CA (1) CA2367214C (cs)
CO (1) CO4970741A1 (cs)
CZ (1) CZ299820B6 (cs)
DE (1) DE60010452T2 (cs)
DK (1) DK1165138T3 (cs)
ES (1) ES2219331T3 (cs)
HK (1) HK1044892B (cs)
HU (1) HU229252B1 (cs)
IL (2) IL145630A0 (cs)
MX (1) MXPA01009862A (cs)
NO (1) NO327210B1 (cs)
NZ (1) NZ514964A (cs)
PL (1) PL199569B1 (cs)
PT (1) PT1165138E (cs)
RU (1) RU2226395C2 (cs)
SK (1) SK287244B6 (cs)
TW (1) TWI241194B (cs)
WO (1) WO2000059542A1 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788799A3 (en) 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
ATE333271T1 (de) * 2003-02-21 2006-08-15 Schering Ag Uv-stabiles transdermales pflaster
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
EP1719504A1 (de) * 2005-05-02 2006-11-08 Schering AG Festes transdermales therapeutisches System mit UV-Absorber
RU2419435C2 (ru) * 2005-07-22 2011-05-27 Такеда Фармасьютикал Компани Лимитед Предотвращающий преждевременную овуляцию агент
US9585854B2 (en) * 2012-11-09 2017-03-07 Iasomai Ab N-acetyl-L-cysteine for use in in vitro fertilization
WO2016044271A2 (en) 2014-09-15 2016-03-24 Children's Medical Center Corporation Methods and compositions to increase somatic cell nuclear transfer (scnt) efficiency by removing histone h3-lysine trimethylation
DK3662925T3 (da) 2015-04-17 2021-06-28 Ferring Bv Sammensætning, der omfatter fsh, til behandling af infertilitet
WO2018060438A1 (en) * 2016-09-30 2018-04-05 Myovant Sciences Gmbh Methods of treating female infertility
RU2665967C1 (ru) * 2017-06-14 2018-09-05 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ стимуляции роста фолликулов в программах экстракорпорального оплодотворения у пациенток с бесплодием различного генеза и "бедным ответом на стимуляцию"
CN107982520A (zh) * 2017-12-25 2018-05-04 上海交通大学医学院附属第九人民医院 外源性MPA与hMG在制备动物模型药物中的应用
CN110570952B (zh) * 2018-06-05 2022-04-12 北京大学第三医院 预测拮抗剂方案下受试者卵巢低反应概率的系统及指导促性腺激素起始用药剂量选择的系统
CN110491505B (zh) * 2019-08-22 2021-06-01 北京大学第三医院（北京大学第三临床医学院） 预测受试者卵巢刺激过程中获得的卵母细胞数量的系统
CN113456801A (zh) * 2021-08-05 2021-10-01 浙江大学医学院附属第四医院 人绒毛膜促性腺激素在制备早发性卵巢功能不全患者的助孕药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016259A (en) * 1974-07-26 1977-04-05 Research Corporation Contraceptive polypeptides
ATE65407T1 (de) * 1984-04-03 1991-08-15 Serono Lab Verfahren zur herbeifuehrung der ovulation.
AU5281990A (en) 1989-03-10 1990-10-09 Endorecherche Inc. Combination therapy for treatment of estrogen sensitive diseases
US5470847A (en) * 1993-12-10 1995-11-28 Board Of Regents, The University Of Texas System Ovulation control by regulating nitric oxide levels with arginine derivatives
EP0769956B1 (en) 1994-07-22 2000-03-15 The Medical College Of Hampton Roads USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS
EP0788799A3 (en) 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
CA2200541C (en) 1997-01-22 2013-02-19 Philippe Bouchard Lhrh-antagonists in the treatment of fertility disorders
AU4325797A (en) * 1997-06-23 1999-01-04 Mcneil-Ppc, Inc. Acetaminophen and cisapride analgesics
SI1082129T1 (en) * 1998-04-23 2004-02-29 Zentaris Gmbh Method for the treatment of fertility disorders

Also Published As

Publication number Publication date
AU4106900A (en) 2000-10-23
US8173592B1 (en) 2012-05-08
DK1165138T3 (da) 2004-08-30
WO2000059542A9 (en) 2001-11-22
AR023249A1 (es) 2002-09-04
MXPA01009862A (es) 2003-10-14
RU2226395C2 (ru) 2004-04-10
HK1044892B (zh) 2011-06-30
EP1165138A1 (en) 2002-01-02
AU768544B2 (en) 2003-12-18
NZ514964A (en) 2003-08-29
CA2367214C (en) 2008-07-29
JP2002541122A (ja) 2002-12-03
CN1346281B (zh) 2010-04-14
CZ299820B6 (cs) 2008-12-03
JP4616999B2 (ja) 2011-01-19
DE60010452T2 (de) 2005-04-14
TWI241194B (en) 2005-10-11
NO20014736L (no) 2001-11-26
WO2000059542A1 (en) 2000-10-12
BG106045A (en) 2002-05-31
IL145630A (en) 2009-09-01
PL351327A1 (en) 2003-04-07
ES2219331T3 (es) 2004-12-01
CA2367214A1 (en) 2000-10-12
BG65270B1 (bg) 2007-11-30
CN1346281A (zh) 2002-04-24
HU229252B1 (en) 2013-10-28
CO4970741A1 (es) 2000-11-07
SK287244B6 (sk) 2010-04-07
KR100679880B1 (ko) 2007-02-07
HK1044892A1 (en) 2002-11-08
ATE265862T1 (de) 2004-05-15
HUP0200431A3 (en) 2004-04-28
CZ20013495A3 (cs) 2002-06-12
SK13842001A3 (sk) 2002-09-10
KR20010105401A (ko) 2001-11-28
PL199569B1 (pl) 2008-10-31
DE60010452D1 (de) 2004-06-09
HUP0200431A2 (hu) 2002-07-29
NO20014736D0 (no) 2001-09-28
NO327210B1 (no) 2009-05-11
BR0009477A (pt) 2002-01-08
EP1165138B1 (en) 2004-05-06
PT1165138E (pt) 2004-09-30

Similar Documents

Publication Publication Date Title
GC0000192A (en) Method for creating a wellbore
IL154421A0 (en) A method for timing control
GB0000867D0 (en) A system and method for controlling a remote machine
GB2357201B (en) Method and apparatus for controlling a synchronous motor
EP1223470A4 (en) PATTERN GENERATION METHOD
IL145630A0 (en) Method for a programmed controlled ovarian stimulation protocol
GB2357401B (en) Method for updating a timing offset in a communication device
GB0019066D0 (en) A method of processing commands
HUP0202651A3 (en) Method for producing l-phenylephrine hydrochloride
GB9900070D0 (en) Control method
GB0023003D0 (en) Method and apparatus for setting a parameter
HUP0202226A3 (en) Method for controlling insects
SG96669A1 (en) A method and apparatus for programming a paste dispensing machine
ZA200107974B (en) Method for a programmed controlled ovarian stimulation protocol.
GB9928767D0 (en) A control method
HUP0300173A3 (en) Method for preparing a thiophene derivative
HK1035237A1 (en) A method for auto-recovering a clock pulse setting
EP1151141A4 (en) PROCESS FOR THE TREATMENT OF ANEMIA
AU3986300A (en) A method for controlling nematodes
GB2358324B (en) Method for fast retrain for g.lite
IL149265A0 (en) Method for producing n-substituted 2-pyrazoline-5-one
IL148960A (en) Method for programming a reference cell
HUP0201851A2 (en) Method for regulating a rotational speed
GB9914436D0 (en) A method
GB9902406D0 (en) Apparatus for closing off a passage